NCT02535494View on ClinicalTrials.gov

Risks and Benefits of Naloxone Prescribing

NACompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2021

Study Completion Date

December 31, 2021

Conditions
Opioid Overdose
Interventions
OTHER

Extensive training

We have developed a more in-depth education package to help participants better recognize and respond to an opioid overdose.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

Indivior Inc.
All Listed Sponsors
collaborator

Indivior Inc.

INDUSTRY

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER